valproic acid has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 14 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Disruptive, Impulse Control, and Conduct Disorders: Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty-two subjects with DSM-IV-defined pathological gambling entered a 14-week single-blind trial with lithium (N = 23) or valproate (N = 19)." | 9.10 | Lithium and valproate treatment of pathological gambling: a randomized single-blind study. ( Hollander, E; Pallanti, S; Quercioli, L; Sood, E, 2002) |
| "Forty-two subjects with DSM-IV-defined pathological gambling entered a 14-week single-blind trial with lithium (N = 23) or valproate (N = 19)." | 5.10 | Lithium and valproate treatment of pathological gambling: a randomized single-blind study. ( Hollander, E; Pallanti, S; Quercioli, L; Sood, E, 2002) |
| "The objectives of this study were to determine whether autistic children taking levetiracetam (1) showed improvement in the areas of aggression, impulsivity, hyperkinesis, and mood instability, and (2) showed a nootropic response." | 5.10 | Levetiracetam in autistic children: an open-label study. ( Rugino, TA; Samsock, TC, 2002) |
| "In the treatment of kleptomania, only naltrexone was effective." | 2.82 | Pharmacotherapy of impulse control disorders: A systematic review. ( Maaz, M; Naidoo, Y; Naufal, R; Tahir, R; Tahir, T; Wong, MM, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Tahir, T | 1 |
| Wong, MM | 1 |
| Maaz, M | 1 |
| Naufal, R | 1 |
| Tahir, R | 1 |
| Naidoo, Y | 1 |
| Hlal, H | 1 |
| Barrimi, M | 1 |
| Kettani, N | 1 |
| Rammouz, I | 1 |
| Aalouane, R | 1 |
| Santos-Cubiñá, J | 1 |
| Torres-Rodríguez, A | 1 |
| Castaing-Lespier, PA | 1 |
| Sabaté, N | 1 |
| Torres-Martin, A | 1 |
| Carlo, S | 1 |
| Coccaro, EF | 1 |
| Lee, R | 1 |
| Breen, EC | 1 |
| Irwin, MR | 1 |
| Hicks, CW | 1 |
| Pandya, MM | 1 |
| Itin, I | 1 |
| Fernandez, HH | 1 |
| Sriram, A | 1 |
| Ward, HE | 1 |
| Hassan, A | 1 |
| Iyer, S | 1 |
| Foote, KD | 1 |
| Rodriguez, RL | 1 |
| McFarland, NR | 1 |
| Okun, MS | 1 |
| Pallanti, S | 2 |
| Quercioli, L | 1 |
| Sood, E | 1 |
| Hollander, E | 2 |
| Rugino, TA | 1 |
| Samsock, TC | 1 |
| Yehya, N | 1 |
| Saldarini, CT | 1 |
| Koski, ME | 1 |
| Davanzo, P | 1 |
| DeCaria, CM | 1 |
| Grant, JE | 1 |
| Urpe, M | 1 |
| Kmetz, GF | 1 |
| McElroy, SL | 1 |
| Collins, DJ | 1 |
| Donovan, SJ | 1 |
| Stewart, JW | 1 |
| Nunes, EV | 1 |
| Quitkin, FM | 1 |
| Parides, M | 1 |
| Daniel, W | 1 |
| Susser, E | 1 |
| Klein, DF | 1 |
| Buchalter, EN | 1 |
| Lantz, MS | 1 |
| Szymanski, HV | 1 |
| Olympia, J | 1 |
1 review available for valproic acid and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Pharmacotherapy of impulse control disorders: A systematic review.
Topics: Antidepressive Agents; Disruptive, Impulse Control, and Conduct Disorders; Fluoxetine; Humans; Valpr | 2022 |
4 trials available for valproic acid and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Inflammatory markers and chronic exposure to fluoxetine, divalproex, and placebo in intermittent explosive disorder.
Topics: Adult; Aggression; Biomarkers; C-Reactive Protein; Disruptive, Impulse Control, and Conduct Disorder | 2015 |
Lithium and valproate treatment of pathological gambling: a randomized single-blind study.
Topics: Anticonvulsants; Disruptive, Impulse Control, and Conduct Disorders; Drug Administration Schedule; F | 2002 |
Levetiracetam in autistic children: an open-label study.
Topics: Aggression; Anticonvulsants; Autistic Disorder; Cetirizine; Child; Child Behavior Disorders; Child, | 2002 |
Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.
Topics: Adolescent; Ambulatory Care; Anticonvulsants; Attention Deficit and Disruptive Behavior Disorders; C | 2000 |
9 other studies available for valproic acid and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
["Factitious disorder and skin picking: Clinical approach". A case report].
Topics: Alprazolam; Anxiety Disorders; Comorbidity; Diagnosis, Differential; Disruptive, Impulse Control, an | 2014 |
Exacerbation of mood symptoms associated to primary and secondary carnitine deficiency: a case report.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Attention Deficit Disorder with Hyperactivity; Benzo | 2013 |
Valproate for the treatment of medication-induced impulse-control disorders in three patients with Parkinson's disease.
Topics: Adult; Anticonvulsants; Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Hu | 2011 |
Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Anticonvulsants; Carbidopa; Disruptive, Impulse Co | 2013 |
Valproate-induced hyperammonemic encephalopathy.
Topics: Aggression; Anticonvulsants; Attention Deficit and Disruptive Behavior Disorders; Child; Diagnosis, | 2004 |
Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS).
Topics: Adult; Disruptive, Impulse Control, and Conduct Disorders; Female; Fluvoxamine; Gambling; Humans; Li | 2005 |
Response of kleptomania and mixed mania to valproate.
Topics: Adult; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Comorbidity; Di | 1997 |
Treatment of impulsivity and aggression in a patient with vascular dementia.
Topics: Aged; Aggression; Antimanic Agents; Dementia, Vascular; Disruptive, Impulse Control, and Conduct Dis | 2001 |
Divalproex in posttraumatic stress disorder.
Topics: Adult; Aggression; Disruptive, Impulse Control, and Conduct Disorders; Humans; Male; Stress Disorder | 1991 |